Two Excedrin products temporarily discontinued, company says

National

Pharmaceutical company GlaxoSmithKline says it has temporarily discontinued two types of Excedrin items as a precautionary measure.

The company has suspended production and distribution of its Excedrin Extra Strength and Excedrin Migraine products, it said.

“Through routine quality control and assurance measures, we discovered inconsistencies in how we transfer and weigh ingredients for Excedrin Extra Strength Caplets and Geltabs, and Excedrin Migraine Caplets and Geltabs,” it said in a statement to CNN.

The company does not believe that the product poses a safety risk to consumers but has voluntarily implemented the measure as a precaution, it said.

“We are working hard to resolve the issue as quickly as possible, but at this point in time cannot confirm a definite date as to when supply will resume,” it said. “Other Excedrin products are available along with other pain-relieving drugs, but dosages may differ. Consumers should consult their pharmacist for the most suitable alternative product.”

GlaxoSmithKline described it as a short term issue, saying it expects production to resume shortly.

Trademark and Copyright 2020 Cable News Network, Inc., a Time Warner Company. All rights reserved.

30 Second Downloads

As COVID-19 cases rise, so does food insecurity

Thumbnail for the video titled "As COVID-19 cases rise, so does food insecurity"

Texas Medical Association ranked the risk of getting COVID-19 at various places

Thumbnail for the video titled "Texas Medical Association ranked the risk of getting COVID-19 at various places"

American scientists and engineers being featured on new innovation stamps

Thumbnail for the video titled "American scientists and engineers being featured on new innovation stamps"

Don't Miss

Popular

Latest News

More News